Glutathione

Glutathione is an endogenous tripeptide (glutamate, cysteine, glycine) that plays a central role in intracellular redox balance and detoxification.

Exogenous glutathione is sometimes administered in wellness, hepatology, and dermatology contexts, though practice and evidence differ by region.

Glutathione participates in antioxidant defenses, conjugation of certain xenobiotics, and maintenance of other antioxidant systems.

Potential roles have been studied in liver disease, oxidative stress states, and cosmetic skin-lightening, among others. Only some of these uses may be supported or approved in specific settings.

Parenteral products require attention to sterility, excipients, and infusion reactions. Cosmetic or wellness uses may not have the same level of evidence or regulatory oversight as labeled medical indications.

Glutathione has poor oral bioavailability, leading to a preference for parenteral or liposomal administration in therapeutic settings.

This information summarizes commonly discussed practices. IV administration is often combined with Vitamin C to prevent oxidation.

Glutathione is available as injectable solutions, oral capsules, topical preparations, and compounded "drip" blends with vitamins and other agents. The routes carry very different evidence: a 2025 systematic review found oral glutathione at 250–500 mg daily and topical 0.5% produced significant melanin-index reductions versus placebo, while concluding that "IV glutathione is contraindicated due to lack of efficacy and side effects" (PMID 39444151).

Combination drips add further variables — an adverse reaction to a multi-agent infusion cannot be attributed to a single ingredient afterwards.

Evidence spans basic science, small clinical trials, and cosmetic reports. Findings are context-specific and do not support broad claims of detoxification or anti-aging.

For deeper dives on this peptide, see:

• Glutathione benefits and areas of interest
• Glutathione side effects and safety context
• Glutathione dosing concepts (educational)
• Glutathione research and evidence overview

Does glutathione lighten skin? Modestly and temporarily, by the oral and topical routes. A 2025 systematic review in the International Journal of Dermatology found multiple randomized trials of oral glutathione at 250–500 mg daily producing significant melanin-index reductions versus placebo, and topical 0.5% outperforming 0.1% and placebo — while describing the outcomes as unsustainable, meaning they do not persist after treatment stops (PMID 39444151).

What about IV glutathione? The same review found a single placebo-controlled intravenous study and concluded that "IV glutathione is contraindicated due to lack of efficacy and side effects." Two other dermatology reviews agree: one notes the IV route prompted regulatory warnings from the Philippine FDA (PMID 27088927), and another cautions against it on adverse-event grounds while listing oral glutathione among promising systemic agents (PMID 30133125).

What did the main oral trial actually show? A 12-week three-arm randomized, double-blind trial — 60 enrolled, 57 completing — compared GSH 250 mg/day, GSSG 250 mg/day, and placebo. Melanin index tended lower but reached significance only in subgroup analysis; wrinkle reduction was significant for GSH at the sun-protected arm site (P=0.006); adverse effects occurred in 13.15% of glutathione participants versus 21.05% on placebo. All participants were female, Asian, and within a defined age range (Weschawalit et al., 2017).

Is glutathione a peptide? Technically yes — a tripeptide of glutamate, cysteine, and glycine — though it functions as a redox cofactor rather than as a signaling peptide.

Is it FDA-approved? No. In the United States it is sold as a dietary supplement and is not an approved drug for antioxidant, anti-aging, or skin-lightening indications. Injectable skin-lightening preparations are unapproved for those uses.